Indexed with PubMed and Science Citation Index (E) 
Users online: 508 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
   Next article
   Previous article 
   Table of Contents
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Article in PDF (96 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

  In this article
   Article Tables

 Article Access Statistics
    PDF Downloaded252    
    Comments [Add]    
    Cited by others 3    

Recommend this journal


Year : 2008  |  Volume : 74  |  Issue : 3  |  Page : 277-278

Role of free reactive iron in psoriasis

Department of Biochemistry, NRS Medical College and Hospital, Kolkatta, West Bengal, India

Correspondence Address:
Manoj Kar
Department of Biochemistry, NRS Medical College and Hospital, Kolkatta
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0378-6323.41390

Rights and Permissions

How to cite this article:
Ghosh A, Mukhopadhyay S, Kar M. Role of free reactive iron in psoriasis. Indian J Dermatol Venereol Leprol 2008;74:277-8

How to cite this URL:
Ghosh A, Mukhopadhyay S, Kar M. Role of free reactive iron in psoriasis. Indian J Dermatol Venereol Leprol [serial online] 2008 [cited 2020 Dec 6];74:277-8. Available from:


Psoriasis is a chronic, inflammatory autoimmune skin disease. [1] Recently, oxidative stress has been implicated in the etiopathology of psoriasis. Reduced level of serum super oxide dismutase (SOD), glutathione peroxidase (GPX), and elevated level of nitric oxide (NO) has been reported. [2],[3],[4] The causative factor of such oxidative stress is not yet clearly known. In psoriatic plaque blood capillaries are dilated and become tortuous to form loops which may cause breakdown of erythrocytes to release hemoglobin. Moreover, low GPX and SOD may help to elevate the level of hydrogen peroxide (H 2 O 2 ) which further causes break down of hemoglobin within erythrocyte to form nonheme reactive iron. This free reactive iron can catalyze Haber-Weiss reaction and generate deadly damaging hydroxyl radical which in turn damage cellular constituents. [5]

To investigate whether free reactive iron has any role in secondary pathogenesis of psoriatic lesion, we sought to study the level of free reactive iron in stroma free hemolysate. Serum level of cellular damage marker thiobarbituric acid reacting substance (TBARS), total thiol, total antioxidant status (TAS), and ferritin were also measured from blood sample of psoriasis patients by standard methods [Table 1].

Sixteen patients were selected for our study (13 males and 3 females) and all had stable plaque type psoriasis, two with psoriasic arthritis. Patients were within the age group of 25-36. The psoriasis area severity index of the patients ranged from 10 to 60. The mean level of free reactive iron from stroma free hemolysate (214.91 μgm/g of Hb) as compared to that of normal control volunteers (118.15 μg/g of Hb) and the cellular damage marker TBARS (3.23 nmol/ml) compare to that of normal control volunteers (1.31 nmol/ml) were found to highly significant ( P < 0.001) and significant ( P < 0.05), respectively. The TAS level was also found to be significantly low (0.6 Trolox equivalent) when compare to normal control (1.37 Trolox equivalent). The values of total thiol and ferritin were not statistically significantly different, but mean values were lower for total thiol and higher for ferritin.

Ferrous iron with six coordination states is bound and tamed within protoporphyrin ring of hemoglobin. Under specific circumstances like oxidative stress or over production of H 2 O 2 , it comes out of the ring and can ligate with other part of globin chain. This non-heme iron has been termed free reactive iron which can generate cytotoxic hydroxyl radical by Fenton reaction in presence of H 2 O 2 . [5]

Our findings indicate the increase in level of free reactive iron and lower level of antioxidant status in psoriasis. This may contribute via free radical generation to the development of secondary cellular damage and pathological state in psoriasis vulgaris. Therapeutic use of iron chelator and antioxidant drugs may be investigated for beneficial role in psoriasis.

  References Top

1.Davidson. Psoriasis. In : Principles and Practice of Medicine. 18 ed. 2002. p. 900.  Back to cited text no. 1    
2.Wang H, Peters T, Kess D, Sindrilaru A, Oreshkova T, Van Rooijen N, et al. Activated macrophages are essential in murine model for T-cell mediated chronic Psoriasiform skin inflammation. J Clin Invest 2006;116:2105-14.  Back to cited text no. 2  [PUBMED]  [FULLTEXT]
3.Yildirim M, Inaloz HS, Baysal V, Delibas N. The role of oxidants and antioxidants in Psoriasis. J Eur Acad Dermatol Venereol 2003;17:34-6.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]
4.Trouba KJ, Hamadeh HK, Amin RP, Germolec DR. Oxidative stress and its role in skin disease. Antioxid Redox Signal 2002;4:665-73.  Back to cited text no. 4  [PUBMED]  [FULLTEXT]
5.Gokhale NR, Belgaumkar VA, Pandit DP, Deshpande S, Damle DK. A study of serum nitric oxide level in psoriasis. Indian J Dermatol Venereol Leprol 2005;71:175-8.  Back to cited text no. 5    


  [Table 1]

This article has been cited by
1 Effect of narrowband ultraviolet B therapy on inflammatory markers and body fat composition in moderate to severe psoriasis
J. Romaní,A. Caixàs,J.M. Carrascosa,M. Ribera,M. Rigla,J. Luelmo
British Journal of Dermatology. 2012; 166(6): 1237
[Pubmed] | [DOI]
2 The Effects of FeCl3 and Fe–EDTA on the Development of Psoriasis
Qiang Shi, Xiao-qian Yang, Xi Cui
Biological Trace Element Research. 2011; 140(1): 73
[VIEW] | [DOI]
3 Dyslipidemia and oxidative stress in patients of psoriasis
Gupta, M., Chari, S., Borkar, M., Chandankhede, M.
Biomedical Research. 2011; 22(2): 221-224


Print this article  Email this article
Previous article Next article


Online since 15th March '04
Published by Wolters Kluwer - Medknow